INMB - INmune Bio reports Q1 GAAP EPS of -$0.61
2024-05-09 16:40:03 ET
More on INmune Bio
- INmune Bio: An Opportunity In The Freefall (Rating Upgrade)
- INmune Bio, Inc. (INMB) Q4 2023 Earnings Call Transcript
- INmune Bio provides update on Alzheimer's candidate XPro
- INmune Bio rises 2%, on $4.5M direct offering
- Seeking Alpha’s Quant Rating on INmune Bio